Acesso livre
Acesso livre

Infectologia

[Ainda não publicado] Dados iniciais da África do Sul mostram que, diante de infecção pela variante Ômicron, a proteção vacinal pode cair a 30%, mas ainda impede a doença grave.

15 Dez, 2021 | 12:40h

Vaccine protection vs. omicron infection may drop to 30% but does cut severe disease – NPR

Ver também: South Africa Omicron study finds drop in vaccine protection, fewer hospitalized – CIDRAP

COVID-19 em 2022: o controle da pandemia está ao nosso alcance.

15 Dez, 2021 | 12:38h

COVID-19 in 2022: controlling the pandemic is within our grasp – Nature Medicine

 

Comentários no Twitter

 

Consenso de especialistas e diretriz prática | Perspectiva global sobre a melhora no cuidado do paciente com infecção de trato urinário não complicada.

15 Dez, 2021 | 12:36h

A global perspective on improving patient care in uncomplicated urinary tract infection: Expert consensus and practical guidance – Journal of Global Antimicrobial Resistance

Revisão | Diagnóstico e tratamento da apendicite aguda em adultos.

15 Dez, 2021 | 12:30h

Diagnosis and Management of Acute Appendicitis in Adults: A Review – JAMA (gratuito por tempo limitado)

Entrevista com o autor: Current Management of Acute Appendicitis: Antibiotics or Surgical Intervention

Comentário: Antibiotics can be first-line therapy for uncomplicated appendicitis cases – Duke University Medical Center

Aprendizado sobre doenças infecciosas a partir de pacientes internados por tais doenças.

15 Dez, 2021 | 12:23h

ID Learning Units from Inpatient ID Consults – HIV and ID Observations

Ômicron: apresentação técnica atualizada da OMS e ações de prioridade.

14 Dez, 2021 | 16:20h

Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States – World Health Organization

 

Comentário no Twitter (fio – clique para saber mais)

 

Subtipos propostos de “long Covid” e suas respectivas terapias potenciais.

14 Dez, 2021 | 16:18h

Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies – Reviews in Medical Virology

Conteúdos relacionados:

EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

Recomendações para uma recuperação equitativa da pandemia de COVID-19 no Canadá.

14 Dez, 2021 | 16:16h

Recommendations for equitable COVID-19 pandemic recovery in Canada – Canadian Medical Association Journal

Comunicado de imprensa: Equitable COVID-19 pandemic recovery in Canada: New guideline – Canadian Medical Association Journal

Editorial: Build back more equitably

[Preprint] Variante Ômicron do SARS-CoV-2 escapa da neutralização via soro de pessoas vacinadas e convalescentes.

14 Dez, 2021 | 16:15h

[Preprint] SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals – medRxiv

Comentário: SARS-CoV-2 omicron variant may evade host immune responses – News Medical

 

Comentário no Twitter (fio – clique para saber mais)

 

[Preprint] Estudo mostra neutralização reduzida da variante Ômicron do SARS-CoV-2 pelo soro pós-imunização.

14 Dez, 2021 | 16:14h

[Preprint] Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum – medRxiv

Comunicado de imprensa: Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant – University of Oxford

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.